Margaret K. Vandervoort

London, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis.

Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis.

Journal: Alimentary pharmacology & therapeutics

Published: December 20, 2016

The development of a magnetic resonance imaging index for fistulising Crohn's disease.

The development of a magnetic resonance imaging index for fistulising Crohn's disease.

Journal: Alimentary pharmacology & therapeutics

Published: October 29, 2016

Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.

Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.

Journal: Journal of Crohn's & colitis

Published: December 11, 2015

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.

Journal: Lancet (London, England)

Published: September 07, 2015

Development and validation of a histological index for UC.

Development and validation of a histological index for UC.

Journal: Gut

Published: July 17, 2015

Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials.

Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials.

Journal: Alimentary pharmacology & therapeutics

Published: June 15, 2015

Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease.

Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease.

Journal: Gut

Published: December 05, 2014

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity.

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity.

Journal: Alimentary pharmacology & therapeutics

Published: July 30, 2014

Reproducibility of histological assessments of disease activity in UC.

Reproducibility of histological assessments of disease activity in UC.

Journal: Gut

Published: April 24, 2014

Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices.

Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices.

Journal: Inflammatory bowel diseases

Published: January 14, 2014

Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2).

Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2).

Journal: Journal of hypertension

Published: June 08, 2013

Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease.

Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease.

Journal: Gastroenterology

Published: April 16, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026